Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: buprenorphine + naloxone
What it is used for
Treatment of opiate dependence within a framework of medical, social, and pyschological treatment.
How to take it
The way to take this medicine is: Sublingual. This medicine is placed under the tongue.
- Store below 25 degrees Celsius
- Shelf lifetime is 1 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Orange film imprinted with white ink.
Do I need a prescription?
This medicine requires authorisation for prescription from your doctor.It is
Pregnant or planning a pregnancy?
For the active ingredient buprenorphine + naloxone
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Opioid withdrawal management :: SA Health
Symptoms are similar for all opioids, but are of varying severity and duration depending on opioid taken.
Read more on SA Health website
National Drug Strategy - National clinical guidelines and procedures for the use of buprenorphine in the treatment of opioid dependence
These guidelines have been developed to assist in the safe and effective provision of buprenorphine treatment in Australia.
Read more on Department of Health website